Fast Growing China Pharmaceutical Market
Executive Summary
The pharmaceutical industry in China, which is the world's second largest pharmaceutical market after the US, promises robust growth in the coming years. The growth is boosted by the growing aging population, increasing wealth and government reforms. It is expected that in 2020 33% of the Chinese population will be 50 years or older as compared with 24% in 2010. Also chronic illnesses such as hypertension and diabetes are on the rise.
The sector is going through an exciting phase with the government implementing various healthcare reforms and local companies becoming increasingly competitive. Spending in the sector is expected to increase from USD 357 billion in 2011 to approximately USD 1 trillion in 2020.
Why should the report be purchased?
The report 'Fast Growing China Pharmaceutical Market” highlights key dynamics of China's growing pharmaceutical market. The growing opportunity in the sector has been investigated. The initiatives and performance of key players along with current market scenario has also been examined. The report contains latest industry leaders verbatim.
Research methodology and delivery time
Smart Research Insights has conducted in depth secondary research to arrive at key insights. Data collected from key public industry sources and publications has been scanned and analyzed impartially to present a clear picture of the industry. All recent developments which impact the sector dynamics have been captured and used to support the research hypothesis.
The report is available as single-site single-user license. The delivery time for the electronic version of the report is 5 business days as each copy undergoes thorough quality check and is updated with the most recent information available. The delivery time for hard copies is approximately 8 business days, as each hard copy is custom printed for the client
About Smart Research Insights (SRI)
SRI is a research organization specializing in industry research reports and custom research. Our team of dedicated researchers with rich experience across industry segments focuses on delivering high quality analysis. Undertaking in-depth secondary research we arrive at key insights, which are supported by data that has been analyzed impartially to present a clear picture of the industry. All recent developments and industry opinions which impact the sector dynamics are captured and used to support the research hypothesis.
The pharmaceutical industry in China, which is the world's second largest pharmaceutical market after the US, promises robust growth in the coming years. The growth is boosted by the growing aging population, increasing wealth and government reforms. It is expected that in 2020 33% of the Chinese population will be 50 years or older as compared with 24% in 2010. Also chronic illnesses such as hypertension and diabetes are on the rise.
The sector is going through an exciting phase with the government implementing various healthcare reforms and local companies becoming increasingly competitive. Spending in the sector is expected to increase from USD 357 billion in 2011 to approximately USD 1 trillion in 2020.
Why should the report be purchased?
The report 'Fast Growing China Pharmaceutical Market” highlights key dynamics of China's growing pharmaceutical market. The growing opportunity in the sector has been investigated. The initiatives and performance of key players along with current market scenario has also been examined. The report contains latest industry leaders verbatim.
Research methodology and delivery time
Smart Research Insights has conducted in depth secondary research to arrive at key insights. Data collected from key public industry sources and publications has been scanned and analyzed impartially to present a clear picture of the industry. All recent developments which impact the sector dynamics have been captured and used to support the research hypothesis.
The report is available as single-site single-user license. The delivery time for the electronic version of the report is 5 business days as each copy undergoes thorough quality check and is updated with the most recent information available. The delivery time for hard copies is approximately 8 business days, as each hard copy is custom printed for the client
About Smart Research Insights (SRI)
SRI is a research organization specializing in industry research reports and custom research. Our team of dedicated researchers with rich experience across industry segments focuses on delivering high quality analysis. Undertaking in-depth secondary research we arrive at key insights, which are supported by data that has been analyzed impartially to present a clear picture of the industry. All recent developments and industry opinions which impact the sector dynamics are captured and used to support the research hypothesis.
1. GLOBAL PHARMACEUTICAL MARKET OVERVIEW
2. CHINA MACROECONOMIC OVERVIEW
3. PHARMACEUTICAL MARKET IN CHINA
3.1 Market Scenario
3.2 Market Statistics
4. INDUSTRY DRIVERS
5. CHINA GENERIC DRUGS SCENARIO
5.1 Guangzhou Pharmaceutical Holdings
5.2 Xiuzheng Pharmaceutical
5.3 Yangtze River Pharmaceutical Group
5.4 Furen Pharmaceutical Group
5.5 Bayer HealthCare China
6. FUTURE OUTLOOK AND OPPORTUNITIES
7. RESEARCH METHODOLOGY
8. ABOUT SMART RESEARCH INSIGHTS
2. CHINA MACROECONOMIC OVERVIEW
3. PHARMACEUTICAL MARKET IN CHINA
3.1 Market Scenario
3.2 Market Statistics
4. INDUSTRY DRIVERS
5. CHINA GENERIC DRUGS SCENARIO
5.1 Guangzhou Pharmaceutical Holdings
5.2 Xiuzheng Pharmaceutical
5.3 Yangtze River Pharmaceutical Group
5.4 Furen Pharmaceutical Group
5.5 Bayer HealthCare China
6. FUTURE OUTLOOK AND OPPORTUNITIES
7. RESEARCH METHODOLOGY
8. ABOUT SMART RESEARCH INSIGHTS
